Therapeutic targeting in breast cancer for the treatment of liver metastasis: HHEX.
Fuente:
Zenodo
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Recurso digital |
| Publié: |
Zenodo
2025
|
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1866901744652386304 |
|---|---|
| author | Mamoor, Shahan |
| author_facet | Mamoor, Shahan |
| contents | <p dir="ltr">Metastasis is the major cause of death from cancer and metastasis to the liver is a frequent complication of both breast cancer and colorectal cancer, among the two most common cancers that afflict man (1-5). We recently utilized whole transcriptome technologies to define the full complement of differentially expressed kinases and phosphatases in HER2+ breast cancer: in the primary tumor, and in metastasis to the CNS (6-8). Here we utilize whole transcriptome technologies (9, 10) to measure total transcription in the liver metastases of humans with breast cancer, comparing the liver metastatic transcriptome to the primary tumor transcriptome. We identify here a therapeutic target based on its differential expression and up-regulation upon metastasis to the liver, HHEX, as a candidate therapeutic target for the medical management of liver metastasis. </p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_15375889 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Therapeutic targeting in breast cancer for the treatment of liver metastasis: HHEX. Mamoor, Shahan <p dir="ltr">Metastasis is the major cause of death from cancer and metastasis to the liver is a frequent complication of both breast cancer and colorectal cancer, among the two most common cancers that afflict man (1-5). We recently utilized whole transcriptome technologies to define the full complement of differentially expressed kinases and phosphatases in HER2+ breast cancer: in the primary tumor, and in metastasis to the CNS (6-8). Here we utilize whole transcriptome technologies (9, 10) to measure total transcription in the liver metastases of humans with breast cancer, comparing the liver metastatic transcriptome to the primary tumor transcriptome. We identify here a therapeutic target based on its differential expression and up-regulation upon metastasis to the liver, HHEX, as a candidate therapeutic target for the medical management of liver metastasis. </p> |
| title | Therapeutic targeting in breast cancer for the treatment of liver metastasis: HHEX. |
| url | https://doi.org/10.5281/zenodo.15375889 |